Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Oral Health
Published in: BMC Oral Health 1/2021

Open Access 01-12-2021 | Systemic Sclerosis | Research

Oral manifestations of patients with systemic sclerosis: a meta-analysis for case-controlled studies

Authors: Suhan Zhang, Junfei Zhu, Yanshan Zhu, Xiaochao Zhang, Ruifang Wu, Siying Li, Yuwen Su

Published in: BMC Oral Health | Issue 1/2021

Login to get access

Abstract

Background

Systemic sclerosis (SSc) is a multisystem rheumatic disease. Orofacial manifestations are commonly in SSc but maybe usually ignored and overshadowed by other systemic complications. Multiple comparative studies have been conducted to investigate the possible links between SSc and oral manifestations. The present study aimed to investigate the oral health status in patients with SSc.

Methods

Pubmed, Embase, Web of Science, and Scopus were searched up to July 2020. Following outcomes were evaluated: Probing depth (PD), Attachment loss (AL), Bleeding on probing (BOP), Number or percentage of Sites with PD ≥ 4 mm, Prevalence of periodontitis, Number of teeth, Decayed Teeth, Missing teeth, Filled teeth, DMFT index, and the interincisal distance. Newcastle-Ottawa Scale (NOS) were applied for quality assessment. The statistical analysis was processed using the software STATA.

Results

11 eligible studies were included. The maximum interincisor distance was significantly restricted in SSc patients (SMD − 1.061; 95 %CI [− 1.546, − 0.576]; Z = 4.29, P = 0.000).The prevalence of Periodontitis (OR 7.007; 95 %CI [3.529, 13.915]; Z = 5.56, P = 0.000), PD (SMD 3.101; 95 %CI [1.374, 4.829]; Z = 3.52, P = 0.000), AL(SMD 2.584; 95 %CI [0.321, 4.846]; Z = 2.24, P = 0.025), sites with PD ≥ 4mm (SMD 2.071 ; 95 %CI [0.267, 3.875]; Z = 2.25, P = 0.024) and the number of decayed teeth (SMD, 0.186; 95 %CI [0.007, 0.365]; Z = 2.04, P = 0.041) were increased significantly in SSc population in comparison with the controls.

Conclusions

SSc patients have limited mouth opening, higher periodontitis prevalence, and worse periodontal status, as well as an increased number of decayed teeth. Routinely oral hygiene instruction and initial periodontal treatment is recommended for SSc patients.
Appendix
Available only for authorised users
Literature
1.
Sjogren’s syndrome. Br Med J.  1973;4(5884):62–3.
2.
Denton CP. Advances in pathogenesis and treatment of systemic sclerosis. Clin Med (Lond). 2016;16(1):55–60.CrossRef
3.
Isola G et al. Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor (suPAR) levels. J Periodontol. 2020.
4.
Isola G et al. Analysis of galectin-3 levels as a source of coronary heart disease risk during periodontitis. J Periodontal Res. 2021.
5.
Isola G et al. Association among serum and salivary A. actinomycetemcomitans specific immunoglobulin antibodies and periodontitis. BMC Oral Health. 2020;20(1):283.PubMedPubMedCentralCrossRef
6.
Preshaw PM et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55(1):21–31.PubMedCrossRef
7.
Iordache C et al. Volumetric cone beam computed tomography for the assessment of oral manifestations in systemic sclerosis: data from an EUSTAR cohort. J Clin Med. 2019;8(10).
8.
Crincoli V et al. Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study. Int J Mol Sci. 2016;17(7).
9.
Smirani R et al. Impact of systemic sclerosis oral manifestations on patients’ health-related quality of life: a systematic review. J Oral Pathol Med. 2018;47(9):808–15.PubMedCrossRef
10.
Burchfield C, Vorrasi J. Maxillofacial implications of scleroderma and systemic sclerosis: a case report and literature review. J Oral Maxillofac Surg. 2019;77(6):1203–8.PubMedCrossRef
11.
Samulak-Zielińska R, Dembowska E, Lizakowski P. Dental treatment of post-myocardial infarction patients: a review of the literature. Dent Med Probl. 2019;56(3):291–8.PubMedCrossRef
12.
Jagadish R, Mehta DS, Jagadish P. Oral and periodontal manifestations associated with systemic sclerosis: a case series and review. J Indian Soc Periodontol. 2012;16(2):271–4.PubMedPubMedCentralCrossRef
13.
Baron M et al. The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population. Rheumatology. 2014;53(8):1386–94.PubMedCrossRef
14.
Chu CH et al. Oral health of Chinese people with systemic sclerosis. Clin Oral Investig. 2011;15(6):931–9.PubMedCrossRef
15.
da Silva GSG et al. Oral features of systemic sclerosis: a case-control study. Oral Dis. 2019;25(8):1995–2002.CrossRef
16.
Elimelech R et al. Periodontal conditions and tumor necrosis factor-alpha level in gingival crevicular fluid of scleroderma patients. Isr Med Assoc J. 2015;17(9):549–53.
17.
Liberati A et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj. 2009;339:b2700.PubMedPubMedCentralCrossRef
18.
Zhu J et al. Interleukin-6-174G/C polymorphism contributes to periodontitis susceptibility: an updated meta-analysis of 21 case-control studies. Dis Markers. 2016;2016:9612421.
19.
20.
Isola G et al. Risk association between scleroderma disease characteristics, periodontitis, and tooth loss. Clin Rheumato. 2017;36(12):2733–41.PubMedCrossRef
21.
Leung WK et al. Periodontal status of adults with systemic sclerosis: case-control study. J Periodontol. 2011;82(8):1140–5.PubMedCrossRef
22.
Marcucci M, Abdala N. Clinical and radiographic study of orofacial alterations in patients with systemic sclerosis. Braz J Phys. 2009;23(1):82–8.
23.
Mayer, Y., et al., Periodontal condition of patients with autoimmune diseases and the effect of anti-tumor necrosis factor-α therapy. J Periodontol, 2013. 84(2): p. 136–42.PubMedCrossRef
24.
Pischon, N., et al., Increased Periodontal Attachment Loss in Patients With Systemic Sclerosis. Journal of Periodontology, 2016. 87(7): p. 763–771.PubMedCrossRef
25.
Wood, R.E. and P. Lee, Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg Oral Med Oral Pathol, 1988. 65(2): p. 172–8.PubMedCrossRef
26.
TÜrk, İ., et al., Correlations Between Clinical Features and Mouth Opening in Patients With Systemic Sclerosis. Arch Rheumatol, 2020. 35(2): p. 196–204.PubMedPubMedCentralCrossRef
27.
Scardina GA, Mazzullo M,. Messina P. Early diagnosis of progressive systemic sclerosis: the role of oro-facial phenomena. Minerva Stomatol. 2002;51(7–8)311–7.PubMed
28.
Avouac J et al. Systemic sclerosis-associated Sjögren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 2006;54(7):2243–9.PubMedCrossRef
29.
Nagy G et al. Analysis of the oral manifestations of systemic sclerosis. Oral Surg Oral Med Oral Pathol. 1994;77(2):141–6.PubMedCrossRef
30.
Yuen HK et al. Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis. Clin Exp Rheumatol. 2011;29(2 Suppl 65):S26-32.PubMed
31.
Slots J. Periodontitis: facts, fallacies and the future. Periodontology. 2000, 2017;75(1):7–23.
32.
Fischer RG et al. Periodontal disease and its impact on general health in Latin America. Section V: Treatment of periodontitis. Braz Oral Res. 2020;34(supp1 1):e026.PubMedCrossRef
33.
Scardina GA, Pizzigatti ME, Messina P. Periodontal microcirculatory abnormalities in patients with systemic sclerosis. J Periodontol. 2005.76(11):1991–5.PubMedCrossRef
34.
Gamal RM et al. Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis. Immunol Invest. 2018.47(3):241–50.PubMedCrossRef
35.
Taylan A et al. Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: a potential multifaceted relationship between OPG/RANKL/TRAIL and Wnt inhibitors. Mod Rheumatol. 2019;29(4):619–24.PubMedCrossRef
36.
37.
Amaral TN et al. Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum. 2013;43(3):335–47.PubMedCrossRef
38.
39.
Graziani F et al. Is periodontitis and its treatment capable of changing the quality of life of a patient? Br Dent J. 2019;227(7):621–5.PubMedCrossRef
40.
Mizuno H et al. The effects of non-surgical periodontal treatment on glycemic control, oxidative stress balance and quality of life in patients with type 2 diabetes: a randomized clinical trial. PLoS ONE. 2017;12(11):e0188171.PubMedPubMedCentralCrossRef
41.
Monsarrat P et al. The effect of periodontal treatment on patients with rheumatoid arthritis: the ESPERA randomised controlled trial. Joint Bone Spine. 2019;86(5):600–9.PubMedCrossRef
Metadata
Title
Oral manifestations of patients with systemic sclerosis: a meta-analysis for case-controlled studies
Authors
Suhan Zhang
Junfei Zhu
Yanshan Zhu
Xiaochao Zhang
Ruifang Wu
Siying Li
Yuwen Su
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2021
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-021-01603-2

Other articles of this Issue 1/2021

BMC Oral Health 1/2021 Go to the issue

Research article

Relationship between oral health-related knowledge, attitudes, practice, self-rated oral health and oral health-related quality of life among Chinese college students: a structural equation modeling approach

Research article

The effect of rapid maxillary expansion on the upper airway’s aerodynamic characteristics

Research

Investigating inlay designs of class II cavity with deep margin elevation using finite element method

Research

Pathological investigations and correlation research of microfibrillar-associated protein 4 and tropoelastin in oral submucous fibrosis

Research article

Plant-based oral care product exhibits antibacterial effects on different stages of oral multispecies biofilm development in vitro

Research

Old age and other factors associated with salivary microbiome variation